Mondelez International, Inc.

The data on file supports a narrower reading than a headline about growth would suggest. Annual revenue grew about 5.8% in 2025 to $38.54 billion, but the 2024 increase was about 1.2%, so the recent acceleration rests on a single year rather than a steady trend. Because the first-quarter 2026 MD&A excerpt omits its results discussion, readers cannot tell from this data whether the cocoa-driven cost pressure described in the 10-K eased or intensified in early 2026. The filing does describe how the company manages part of that exposure. Item 3 says Mondelez principally uses derivatives to reduce significant, unanticipated earnings fluctuations from currency, commodity and interest rate volatility, with details in Note 6, Financial Instruments. Several other filing items are worth a careful read. The company repurchased no shares in the first quarter of 2026 under its $9.0 billion authorization running through December 31, 2027, leaving about $6.7 billion available. The 10-Q share table also records 456,584 shares tendered by employees in the quarter for option exercises and related taxes, which is a different activity from buybacks. A 364-Day Revolving Credit Agreement dated February 18, 2026 appears as Exhibit 10.1, and the filing points to Note 5 for debt and borrowing arrangements, which is not in this data. Management states that disclosure controls were effective as of March 31, 2026, and that there were no material changes in internal control over financial reporting during the quarter. Forensic scores: none are on file for MDLZ in this data set, so this synthesis does not rely on any. For context, a Beneish M-Score is a screening model that estimates the likelihood of earnings manipulation and calls for a closer read when elevated. A Piotroski F-Score counts accounting and financial health signals. An Altman Z-Score estimates financial distress risk and is not designed for banks or financial firms. A Fog Index estimates how hard a document is to read. Their absence here means no score-based conclusion can be drawn. Readers may want to look at the full 10-K and complete 10-Q, including the legal proceedings in Note 8 and the segment discussion, which this excerpt does not include.

Catalyst.The most recent annual figures show revenue of $38.54 billion for 2025, up from $36.44 billion in 2024, a change of about 5.8%. Growth was slower in 2024, when revenue rose about 1.2% from $36.02 billion in 2023. The MD&A excerpt from the first-quarter 2026 Form 10-Q does not include a results discussion, so this data cannot describe segment or product drivers for the quarter. The 10-K risk factors attribute 2025 cost pressure to soaring cocoa prices, disrupted international supply chains, labor market challenges and higher transportation and labor costs.

Hidden risk.The 10-Q states there were no material changes to the risk factors in the 10-K. Yet the forward-looking list includes benefits from the ERP System Implementation program, restructuring actions not yielding anticipated benefits, and goodwill and intangible asset impairment if valuation factors change significantly. The risk factors also name the company's ability to effectively hedge cocoa and other commodity costs as a concern, so hedging reduces exposure without removing it. Cost pressure from commodities is the item a casual reader could underweight.